Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dynamic imaging of individual remyelination profiles in multiple sclerosis.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Laquinimod Phase IIa Study in Active Crohn's Disease
Estimating Time to Disease Progression Comparing Transition Models and Survival Methods-An Analysis of Multiple Sclerosis Data.
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study.
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
Pharmacokinetic properties and metabolism of idebenone.
Amiloride: a molecular probe of sodium transport in tissues and cells.
Reactive astrocytes as therapeutic targets for CNS disorders.
Treatment of acute transverse myelitis and its early complications.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
Tecfidera(®): an approach for repurposing.
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis.
Role of the Blood-Brain Barrier in Multiple Sclerosis.
High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
Imaging outcomes for trials of remyelination in multiple sclerosis.
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis.
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.

Pages